Have a personal or library account? Click to login
Therapeutic importance, general and endocrine adverse effects of immune checkpoint inhibitors I: mechanism of action and therapeutic use Cover

Therapeutic importance, general and endocrine adverse effects of immune checkpoint inhibitors I: mechanism of action and therapeutic use

Bulletin of Medical Sciences
Volume 95 (2022): Issue 2 (December 2022)
By: Imre Zoltán Kun,  Ildikó Kun,  Margit Hadnagy and  Melinda Kolcsár  
Open Access
|Jun 2024

Download Article

Download the full article as a PDF file.

DOI: https://doi.org/10.2478/orvtudert-2022-0010 | Journal eISSN: 2537-5059 | Journal ISSN: 1453-0953
Journal RSS Feed
Language: English
Page range: 145 - 166
Published on: Jun 7, 2024
Published by: Transylvanian Museum Society
In partnership with: Paradigm Publishing Services
Publication frequency: 2 issues per year
Keywords:
immune checkpoint inhibitors,
ipilimumab,
nivolumab,
pembrolizumab
Related subjects:
Life sciences,
Life sciences, other,
Medicine,
Clinical medicine,
Clinical medicine, other,
Pharmacy,
Pharmacy, other

© 2024 Imre Zoltán Kun, Ildikó Kun, Margit Hadnagy, Melinda Kolcsár, published by Transylvanian Museum Society
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 3.0 License.

Volume 95 (2022): Issue 2 (December 2022)Next article